Please assess the completion status of the following clinical trial:

Trial Title: Learn to Quit-HIV Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV-positive~* Currently engaged with an HIV care provider~* Self-report smoking 5 cigarettes or more per day during the past 30 days~* Age 18 years or older~* Current interest in quitting smoking~* Currently own a functioning Android or Apple smartphone~Exclusion Criteria:~* No desire to quit smoking~* Inability to attend study sessions~* Inability to provide informed consent~* Any medical condition or concomitant medication that could compromise subject safety or treatment, as determined by the Principal Investigators and/or Study Physician~* Presence of contraindications for nicotine patch~* Previous allergic reaction or hypersensitivity to nicotine patch (lifetime)~* Current use of nicotine replacement therapy or other smoking cessation treatment (e.g., bupropion, varenicline)~* Pregnant, planning to become pregnant, nursing, or becoming pregnant during the study~* Current untreated and unstable diagnosis of alcohol/substance abuse or dependence (eligible if past abuse/dependence and if receiving treatment and stable for \>30 days)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Learn to Quit-HIV (Type: EXPERIMENTAL): A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.
- QuitGuide (Type: ACTIVE_COMPARATOR): A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS (United States Department of Health and Human Services) Clinical Practice Guidelines. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).